Granulosa cell tumor of the ovary after long-term use of tamoxifen and toremifene

J Obstet Gynaecol Res. 2012 Dec;38(12):1379-84. doi: 10.1111/j.1447-0756.2012.01878.x. Epub 2012 May 21.

Abstract

The relation between the use of tamoxifen and gynecologic tumors has been documented. In this case, a 58-year-old postmenopausal woman had been treated with tamoxifen for 5 years followed by toremifene for 1.5 years due to the presence of stage II estrogen receptor-positive breast cancer. The patient was found to have a stage Ic granulosa cell tumor of the ovary despite undergoing annual gynecologic examinations. This report presents a case of granulosa cell tumor of the ovary after the long-term use of tamoxifen and toremifene.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / adverse effects*
  • Breast Neoplasms / drug therapy
  • Carcinoma, Ductal, Breast / drug therapy
  • Female
  • Granulosa Cell Tumor / chemically induced*
  • Humans
  • Middle Aged
  • Neoplasms, Second Primary / chemically induced*
  • Ovarian Neoplasms / chemically induced*
  • Tamoxifen / administration & dosage
  • Tamoxifen / adverse effects*
  • Toremifene / administration & dosage
  • Toremifene / adverse effects*

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Toremifene

Supplementary concepts

  • Granulosa cell tumor of the ovary